share_log

Peeling Back The Layers: Exploring RxSight Through Analyst Insights

Peeling Back The Layers: Exploring RxSight Through Analyst Insights

剝離層層: 通過分析師見解探索RxSight
Benzinga ·  09/13 08:00
Ratings for RxSight (NASDAQ:RXST) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去的三個月中,有8位分析師對RxSight(納斯達克股票代碼:RXST)進行了評級,展示了看好和看淡的觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖,顯示了過去30天的不同情緒,並將其與前幾個月進行比較。
In the assessment of 12-month price targets, analysts unveil insights for RxSight, presenting an average target of $64.12, a high estimate of $73.00, and a low estimate of $54.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 7.07%.
In the assessment of 12-month price targets, analysts unveil insights for RxSight, presenting an average target of $64.12, a high estimate of $73.00, and a low estimate of $54.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 7.07%.
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級:更深入的了解
The perception of RxSight...
最近分析...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論